JP2023512213A5 - - Google Patents
Info
- Publication number
- JP2023512213A5 JP2023512213A5 JP2022545825A JP2022545825A JP2023512213A5 JP 2023512213 A5 JP2023512213 A5 JP 2023512213A5 JP 2022545825 A JP2022545825 A JP 2022545825A JP 2022545825 A JP2022545825 A JP 2022545825A JP 2023512213 A5 JP2023512213 A5 JP 2023512213A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- linear
- branched
- group
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062967276P | 2020-01-29 | 2020-01-29 | |
| US62/967,276 | 2020-01-29 | ||
| US202063038278P | 2020-06-12 | 2020-06-12 | |
| US63/038,278 | 2020-06-12 | ||
| US202063040166P | 2020-06-17 | 2020-06-17 | |
| US63/040,166 | 2020-06-17 | ||
| PCT/US2021/015495 WO2021154997A1 (en) | 2020-01-29 | 2021-01-28 | Inhibitors of apol1 and methods of using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512213A JP2023512213A (ja) | 2023-03-24 |
| JP2023512213A5 true JP2023512213A5 (cg-RX-API-DMAC7.html) | 2024-01-31 |
| JP7668804B2 JP7668804B2 (ja) | 2025-04-25 |
Family
ID=74673393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022545825A Active JP7668804B2 (ja) | 2020-01-29 | 2021-01-28 | Apol1の阻害剤およびこれを使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12116343B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4097083A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7668804B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116348447A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021213758A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3168909A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021154997A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3897833T (lt) | 2018-12-17 | 2026-04-27 | Vertex Pharmaceuticals Incorporated | Apol1 inhibitoriai ir jų panaudojimo būdai |
| AU2020328598B2 (en) | 2019-08-15 | 2026-07-02 | Black Diamond Therapeutics, Inc. | Alkynyl quinazoline compounds |
| EP4097083A1 (en) | 2020-01-29 | 2022-12-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of apol1 and methods of using same |
| EP4114385A1 (en) | 2020-03-06 | 2023-01-11 | Vertex Pharmaceuticals Incorporated | Methods of treating apol-1 dependent focal segmental glomerulosclerosis |
| EP4146633A4 (en) | 2020-05-07 | 2024-09-25 | Rambam Med-Tech Ltd. | COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1 |
| JP2023530271A (ja) * | 2020-06-12 | 2023-07-14 | バーテックス ファーマシューティカルズ インコーポレイテッド | Apol1の阻害剤及びこれを使用する方法 |
| CN115867543A (zh) | 2020-06-12 | 2023-03-28 | 弗特克斯药品有限公司 | Apol1抑制剂的固体形式及其使用方法 |
| US20230014907A1 (en) * | 2020-06-12 | 2023-01-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of apol1 and methods of using same |
| BR112023003423A2 (pt) | 2020-08-26 | 2023-03-21 | Vertex Pharma | Inibidores de apol1 e métodos de uso destes |
| KR20240051990A (ko) * | 2021-08-26 | 2024-04-22 | 버텍스 파마슈티칼스 인코포레이티드 | 스피로트리시클릭 apol1 억제제의 고형분 형태 및 이의 사용 방법 |
| US12612379B2 (en) * | 2021-11-30 | 2026-04-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of APOL1 and methods of using same |
| AU2022401847A1 (en) * | 2021-11-30 | 2024-06-06 | Vertex Pharmaceuticals Incorporated | Spirocyclic inhibitors of apol1 and methods of using same |
| MX2024008868A (es) | 2022-01-18 | 2024-09-23 | Maze Therapeutics Inc | Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso. |
| WO2023247670A1 (en) * | 2022-06-24 | 2023-12-28 | F. Hoffmann-La Roche Ag | New heterocyclic-carbonyl-cyclic compounds as magl inhibitors |
| EP4705296A1 (en) * | 2023-05-03 | 2026-03-11 | OmniAB, Inc. | Heteroarylindole inhibitors of apol-1 |
| GB202401326D0 (en) * | 2024-02-01 | 2024-03-20 | Podium Bio Ltd | Novel compounds |
| WO2025231011A1 (en) * | 2024-05-01 | 2025-11-06 | Omniab, Inc. | Heteroarylindole inhibitors of apol-1 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9718833D0 (en) * | 1997-09-04 | 1997-11-12 | Merck Sharp & Dohme | Therapeutic agents |
| EP0924209B1 (en) | 1997-12-19 | 2003-05-02 | Eli Lilly And Company | Hypoglycemic imidazoline compounds |
| GB9905010D0 (en) | 1999-03-04 | 1999-04-28 | Merck Sharp & Dohme | Therapeutic agents |
| WO2001017965A2 (en) | 1999-09-07 | 2001-03-15 | Syngenta Participations Ag | Cyanopiperidines as pesticides |
| FR2801585B1 (fr) | 1999-11-25 | 2002-02-15 | Fournier Ind & Sante | Nouveaux antagonistes des recepteurs de l'ii-8 |
| GB0003397D0 (en) | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
| WO2002028831A1 (en) | 2000-10-02 | 2002-04-11 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| FR2824826B1 (fr) | 2001-05-17 | 2003-11-07 | Fournier Lab Sa | Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8 |
| FR2824827B1 (fr) | 2001-05-17 | 2004-02-13 | Fournier Lab Sa | Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8 |
| MXPA03011886A (es) | 2001-07-05 | 2005-03-07 | Lundbeck & Co As H | Piperidinias anilinicas sustituidas como antagonistas selectivos de mch. |
| KR20050044450A (ko) | 2001-11-14 | 2005-05-12 | 테바 파마슈티컬 인더스트리즈 리미티드 | 로사르탄 칼륨의 무정형 및 결정형 형태 및 이의 제조 방법 |
| WO2003104180A1 (en) | 2002-06-05 | 2003-12-18 | Natco Pharma Limited | Process for the preparation of 4-(4-fluorobenzoyl) butyric acid |
| WO2004058717A1 (en) | 2002-12-20 | 2004-07-15 | X-Ceptor Therapeutics, Inc. | Isoquinolinone derivatives and their use as therapeutic agents |
| AU2004268919A1 (en) | 2003-09-03 | 2005-03-10 | Galapagos Nv | Novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-HT2A receptor-related disorders |
| WO2005092854A1 (en) | 2004-03-03 | 2005-10-06 | Eli Lilly And Company | Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators |
| WO2007061763A2 (en) | 2005-11-22 | 2007-05-31 | Merck & Co., Inc. | Indole orexin receptor antagonists |
| PT2118074E (pt) | 2007-02-01 | 2014-03-20 | Resverlogix Corp | Compostos para a prevenção e tratamento de doenças cardiovasculares |
| EP2178870B1 (en) | 2007-08-17 | 2018-09-19 | LG Chem, Ltd. | Indole and indazole compounds as an inhibitor of cellular necrosis |
| KR101605061B1 (ko) | 2009-05-29 | 2016-03-21 | 라퀄리아 파마 인코포레이티드 | 칼슘 또는 나트륨 채널 차단제로서의 아릴 치환된 카복사미드 유도체 |
| WO2012025155A1 (en) * | 2010-08-26 | 2012-03-01 | Novartis Ag | Hydroxamate-based inhibitors of deacetylases |
| TW201309670A (zh) * | 2011-01-25 | 2013-03-01 | Kissei Pharmaceutical | 吲哚衍生物或其藥理學上容許之鹽 |
| US10130632B2 (en) | 2012-11-27 | 2018-11-20 | Beth Israel Deaconess Medical Center, Inc. | Methods for treating renal disease |
| US9850203B2 (en) | 2013-09-26 | 2017-12-26 | Pharmakea, Inc. | Autotaxin inhibitor compounds |
| ES2895490T3 (es) | 2014-03-27 | 2022-02-21 | Acad Medisch Ct | Iminoazúcares N-(5-(bifen-4-ilmetiloxi)pentil)-sustituidos como inhibidores de glucosilceramida sintasa |
| WO2016029310A1 (en) | 2014-08-27 | 2016-03-03 | The Governing Council Of The University Of Toronto | Cannabinoid type 1 receptor modulators |
| BR112017007178A2 (pt) | 2014-10-08 | 2017-12-19 | Ass Francaise Contre Les Myopathies | compostos de aminopiridina úteis como inibidores de prenilação de proteína |
| HRP20210472T1 (hr) | 2015-08-27 | 2021-05-14 | Pfizer Inc. | Biciklički kondenzirani heteroarilni ili arilni spojevi kao modulatori irak4 |
| EP3787669A4 (en) * | 2018-04-30 | 2022-03-30 | The Trustees of Indiana University | COMPOUNDS FOR MODULATION OF LEVELS OF DDAH AND ADMA AND METHODS OF USE THEM TO TREAT DISEASES |
| CN118127019A (zh) | 2018-05-22 | 2024-06-04 | Ionis制药公司 | Apol1表达的调节剂 |
| LT3897833T (lt) | 2018-12-17 | 2026-04-27 | Vertex Pharmaceuticals Incorporated | Apol1 inhibitoriai ir jų panaudojimo būdai |
| EP4097083A1 (en) | 2020-01-29 | 2022-12-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of apol1 and methods of using same |
| US20210246121A1 (en) | 2020-02-04 | 2021-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of apol1 inhibitor and methods of using same |
| EP4114385A1 (en) | 2020-03-06 | 2023-01-11 | Vertex Pharmaceuticals Incorporated | Methods of treating apol-1 dependent focal segmental glomerulosclerosis |
| EP4146633A4 (en) | 2020-05-07 | 2024-09-25 | Rambam Med-Tech Ltd. | COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1 |
| US20230014907A1 (en) | 2020-06-12 | 2023-01-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of apol1 and methods of using same |
| JP2023530271A (ja) | 2020-06-12 | 2023-07-14 | バーテックス ファーマシューティカルズ インコーポレイテッド | Apol1の阻害剤及びこれを使用する方法 |
| CN115867543A (zh) | 2020-06-12 | 2023-03-28 | 弗特克斯药品有限公司 | Apol1抑制剂的固体形式及其使用方法 |
| BR112023003423A2 (pt) | 2020-08-26 | 2023-03-21 | Vertex Pharma | Inibidores de apol1 e métodos de uso destes |
| KR20240051990A (ko) | 2021-08-26 | 2024-04-22 | 버텍스 파마슈티칼스 인코포레이티드 | 스피로트리시클릭 apol1 억제제의 고형분 형태 및 이의 사용 방법 |
| US12612379B2 (en) | 2021-11-30 | 2026-04-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of APOL1 and methods of using same |
| AU2022401847A1 (en) | 2021-11-30 | 2024-06-06 | Vertex Pharmaceuticals Incorporated | Spirocyclic inhibitors of apol1 and methods of using same |
| EP4476228A1 (en) | 2022-02-08 | 2024-12-18 | Vertex Pharmaceuticals Incorporated | 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using same |
| CN119343353A (zh) | 2022-02-08 | 2025-01-21 | 弗特克斯药品有限公司 | 作为APOL1抑制剂的2-甲基-4',5'-二氢螺[哌啶-4,7'-噻吩并[2,3-c]吡喃]衍生物和其使用方法 |
| WO2023154314A1 (en) | 2022-02-08 | 2023-08-17 | Vertex Pharmaceuticals Incorporated | Spiro piperidine derivatives as inhibitors of apol1 and methods of using same |
| EP4476199A1 (en) | 2022-02-08 | 2024-12-18 | Vertex Pharmaceuticals Incorporated | 2-methyl-4-phenylpiperidin-4-ol derivatives as inhibitors of apol1 and methods of using same |
-
2021
- 2021-01-28 EP EP21707527.4A patent/EP4097083A1/en active Pending
- 2021-01-28 JP JP2022545825A patent/JP7668804B2/ja active Active
- 2021-01-28 WO PCT/US2021/015495 patent/WO2021154997A1/en not_active Ceased
- 2021-01-28 CN CN202180025813.4A patent/CN116348447A/zh active Pending
- 2021-01-28 AU AU2021213758A patent/AU2021213758A1/en active Pending
- 2021-01-28 US US17/161,474 patent/US12116343B2/en active Active
- 2021-01-28 CA CA3168909A patent/CA3168909A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| JP4685068B2 (ja) | 脈管形成阻害活性を有するアリール尿素 | |
| RU2681943C2 (ru) | Соединения, полезные для лечения заболеваний, вызванных ретровирусами | |
| WO2021168193A1 (en) | Pyridopyrimidine derivatives as kras inhibitors | |
| JP2023529216A5 (cg-RX-API-DMAC7.html) | ||
| JP2013515074A5 (cg-RX-API-DMAC7.html) | ||
| JP2025505200A5 (cg-RX-API-DMAC7.html) | ||
| JP2010513519A5 (cg-RX-API-DMAC7.html) | ||
| JP2023530271A5 (cg-RX-API-DMAC7.html) | ||
| JP2013545808A5 (cg-RX-API-DMAC7.html) | ||
| RU2012131416A (ru) | Ингибиторы фосфатидилинозитол-3-киназы на основе изоиндолинона | |
| EA200870384A1 (ru) | 3,7-диамино-10h-фенотиазиновые соли и их применение | |
| JP2018505898A5 (cg-RX-API-DMAC7.html) | ||
| JP2013544812A5 (cg-RX-API-DMAC7.html) | ||
| CA2656716C (fr) | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique | |
| JP2006521336A5 (cg-RX-API-DMAC7.html) | ||
| JP2005514398A5 (cg-RX-API-DMAC7.html) | ||
| JP2012503018A5 (cg-RX-API-DMAC7.html) | ||
| MA30695B1 (fr) | Derives de n-(amino-heteroaryl)-1h-indole -2-carboxamides, leur preparation et leur application en therapeutique. | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| RU2009114802A (ru) | Бензоиламиногетероциклильные соединения в качестве активаторов глюкокиназы (glk) | |
| WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
| JP2025505647A5 (cg-RX-API-DMAC7.html) | ||
| JP2025505644A5 (cg-RX-API-DMAC7.html) | ||
| TW200504070A (en) | 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |